Machine Learning-Based Approach for Early Prediction of Liver Disease
Preprint
- 18 November 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Artificial intelligence and machine learning are increasingly used to support the diagnosis of liver diseases. They help in diagnosing liver diseases more comfortably, offering alternatives to painful treatments like liver biopsy. This research paper reviews 15 recent studies that discuss how AI and ML improve the diagnosis and accuracy of liver diseases. These studies also highlight improvements in feature selection and data handling. The data on liver diseases is imbalanced, with some conditions having much less data than others, making comparison between studies difficult due to varying methods. Additionally, dynamic datasets that change over time are rarely used, limiting deeper analysis of disease progression. This study highlights how AI and ML can improve liver disease diagnosis by addressing data imbalance, enhancing accuracy, and reducing reliance on invasive procedures.Keywords
All Related Versions
This publication has 7 references indexed in Scilit:
- A Machine Learning‐Based Framework for Accurate and Early Diagnosis of Liver Diseases: A Comprehensive Study on Feature Selection, Data Imbalance, and Algorithmic PerformanceInternational Journal of Intelligent Systems, 2024
- Gut microbiome-based machine learning for diagnostic prediction of liver fibrosis and cirrhosis: a systematic review and meta-analysisBMC Medical Informatics and Decision Making, 2023
- Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approachCardiovascular Diabetology, 2022
- Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysisTherapeutic Advances in Gastroenterology, 2021
- Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner studyPLOS ONE, 2020
- Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithmsPLOS ONE, 2020
- Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLDPLOS ONE, 2013